Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy

Study:

n/a

Rationale:

n/a

Purpose:

The purpose of this study is to determine whether ARC-4558 is effective in managing pain associated with painful diabetic neuropathy.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Painful Diabetic Neuropathy Drug: placebo
Drug: topical clonidine (ARC-4558)		 Phase 2

Verified by Arcion Therapeutics Inc January, 2010

Sponsored by: Arcion Therapeutics Inc
Information provided by: Arcion Therapeutics Inc
ClinicalTrials.gov identifier: NCT00695565

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.